Cleared Traditional

K101117 - LEV-OR DILATION CATHETER OTW

K101117 is the FDA 510(k) clearance for LEV-OR DILATION CATHETER OTW by Baylis Medical Co., Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 86-day FDA review.

K101117 · Baylis Medical Co., Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
86d
Days
Class 2
Risk

K101117 is an FDA 510(k) clearance for the LEV-OR DILATION CATHETER OTW. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Baylis Medical Co., Inc. (Mississauga, Ontario, CA). The FDA issued a Cleared decision on July 16, 2010 after a review of 86 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baylis Medical Co., Inc. devices

Submission Details

510(k) Number K101117 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2010
Decision Date July 16, 2010
Days to Decision 86 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 125d · This submission: 86d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 594
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K101117.
OCCLUSION BALLOON CATHETER MODEL OBC
K101877 · Cook, Inc. · Aug 2010
SCOUTPRO ACS
K101776 · Biotronik, Inc. · Jul 2010
SCOUTPRO HEMOSTATIC VALVE
K101282 · Biotronik, Inc. · Jul 2010
PENUMBRA CATHERER 025
K100826 · Penumbra, Inc. · Jul 2010
CLEARWAY OTW MODEL 85912
K093431 · Atrium Medical Corp. · Apr 2010
ACUITY BREAK-AWAY GUIDE CATHETER
K093969 · Cardiac Pacemakers, Inc. · Mar 2010